Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

China · Delayed Price · Currency is CNY

11.16

+0.15 (1.36%)

Oct 28, 2026, 1:15 PM CST

Market Cap	9.16B -38.1%
Revenue (ttm)	4.04B +0.4%
Net Income	721.72M +3.4%
EPS	0.89 +8.6%
Shares Out	820.88M
PE Ratio	12.54
Forward PE	n/a
Dividend	0.35 (3.14%)
Ex-Dividend Date	Jun 11, 2026

Volume	5,317,200
Open	11.15
Previous Close	11.01
Day's Range	10.98 - 11.17
52-Week Range	10.97 - 21.65
Beta	-0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1990

Employees 3,732

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002020

Full Company Profile

Financial Performance

In 2025, SHE:002020's revenue was 4.07 billion, a decrease of -2.14% compared to the previous year's 4.16 billion. Earnings were 757.98 million, an increase of 6.46%.

Financial Statements